Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion

ASAP3 is a downstream target of HIF-1α and is critical for progression of lung adenocarcinoma

(2019) Pingping Zhang et al.   OncoTargets and Therapy

Malignant Pleural Effusion and Its Current Management: A Review

(2019) Skok et al.   Medicina-Lithuania

Correlation Coefficients

(2018) Patrick Schober et al.   ANESTHESIA AND ANALGESIA

CD133: beyond a cancer stem cell biomarker

(2018) Amir Barzegar Behrooz et al.   JOURNAL OF DRUG TARGETING

Management of malignant pleural effusion: challenges and solutions

(2017) Erika Penz et al.   Cancer Management and Research

CD133 expression: a potential prognostic marker for non-small cell lung cancers

(2013) Hidenori Mizugaki et al.   International Journal of Clinical Oncology

Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment

(2012) Jeng-Long Hsieh et al.   CANCER LETTERS

HIF-1α effects on angiogenic potential in human small cell lung carcinoma

(2011) Jun Wan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment

(2011) Rita Mancini et al.   PLoS One

mTOR Signal and Hypoxia-Inducible Factor-1  Regulate CD133 Expression in Cancer Cells

(2009) K. Matsumoto et al.   CANCER RESEARCH